What are different ways to treat chronic myelogenous leukemia?

CML: CML is associated with philadelphia chromosome that result in the abnormal bcr-abl fusion gene. This becomes the target of treatment in cml. Oral tyrosine kinase inhibitor (tki) is the treatment of cml. The 1st generation is gleevec. Other tki that is more specific to block the bcr/abl fusion gene also available- sprycel and tasigna (nilotinib). Bone marrow transplant is available only for specific case.

Medications: The initial treatment for CML is with oral medications called tyrosine kinase inhibitors. For recurrent disease, other chemotherapy drugs or a stem cell transplant may be used.